Bioven Genetics was founded in 2021 by several experienced renowned scientists and entrepreneurs in Canada.  Bioven Genetics established a modern state of art Research and Development site for Androctonus Crassicauda (AC) known, as the Black Scorpion in Sanliurfa Turkiye.

AC is an endemic species, that exists in Mesopotamia more specifically in the southeast part of Turkiye.  The venom of AC is the second-deadliest venom in the world and is extremely scarce as in liquid and purified venom.

Founders of Bioven Genetics decided to expand and become a global company opening a start-up company with Ontario Technology University‘s incubator, Brilliant Catalyst Inc. This critical expansion will enable Bioven Genetics great potential to become a global pharmaceutical enterprise.

Bioven Genetics will work with Turkish partners and Canadian university laboratories/ R&D centers to manufacture novel medical remedies i.e. anti-cancer, rheumatoid pain, etc., and also cosmetic products i.e. anti-aging and anti-wrinkle cream/serum for everyone’s well-being on a global scale.